Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.29 +0.02 (+0.22%)
As of: Sep 30, 2026 · 9:48 AM EDT

Biocryst Pharmaceuticals (BCRX) Operating Expenses (2010 - 2026)

Updated

Biocryst Pharmaceuticals (BCRX) reported Operating Expenses of $119.79 million for Q2 2026, down 10.3% from $133.57 million a year earlier and down 86.0% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Operating Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Biocryst Pharmaceuticals' Operating Expenses came in at $1.25 billion, up 149.1% year-over-year; for FY2025, it was $533.85 million, up 17.8% from FY2024.

  • Operating Expenses has increased for nine consecutive years, with a five-year compound annual growth rate of 22.6% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $453.26 million in FY2024 (+4.2%), $435.12 million in FY2023 (+3.8%), $419.26 million in FY2022 (+25.2%) and $334.89 million in FY2021 (+73.9%).
  • The Q2 2026 figure ranks as the lowest quarterly Operating Expenses since Q3 2024.
  • Year over year, Operating Expenses gained in six of the last eight quarters, with growth averaging 83.2%.
  • The high point for year-over-year Operating Expenses in five years was Q1 2026 (growth of 590.2%); the low point was Q2 2026 (a decline of 10.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $858.01 million (Q1 2026), $146.17 million (Q4 2025) and $129.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Biocryst Pharmaceuticals 2.16 Bn 1.08 Bn 214.41 Mn 119.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119.79 Mn
Mar 31, 2026 858.01 Mn
Dec 31, 2025 146.17 Mn
Sep 30, 2025 129.80 Mn
Jun 30, 2025 133.57 Mn
Mar 31, 2025 124.31 Mn
Dec 31, 2024 136.04 Mn
Sep 30, 2024 109.39 Mn
Jun 30, 2024 100.57 Mn
Mar 31, 2024 107.25 Mn
Dec 31, 2023 136.07 Mn
Sep 30, 2023 98.66 Mn
Jun 30, 2023 103.19 Mn
Mar 31, 2023 97.19 Mn
Dec 31, 2022 125.86 Mn
Sep 30, 2022 93.27 Mn
Jun 30, 2022 100.25 Mn
Mar 31, 2022 99.88 Mn
Dec 31, 2021 99.34 Mn
Sep 30, 2021 85.58 Mn
API Access

Biocryst Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY